Pirtobrutinib (LOXO-305) is a Highly Selective and Non-covalent BTK Inhibitor
Bruton tyrosine kinase (BTK) is a non-receptor kinase and plays a crucial role in carcinogenic signal transduction. Carcinogenic signal transduction is crucial for the proliferation and survival of leukemia cells…